Download PDF
Thromb Haemost 1991; 65(05): 631-634
DOI: 10.1055/s-0038-1648202
Scientific and Standardization Committee Communications
Schattauer GmbH Stuttgart

Recommendations for the Evaluation and Treatment of Neonatal Autoimmune and Alloimmune Thrombocytopenia

J Bussel
The Department of Pediatrics, Cornell Medical College, New York, N.Y., U.S.A., the Institut National de Transfusion Sanguine, Paris, France, and Blood Center of Southeast Wisconsin, U.S.A.
,
C Kaplan
The Department of Pediatrics, Cornell Medical College, New York, N.Y., U.S.A., the Institut National de Transfusion Sanguine, Paris, France, and Blood Center of Southeast Wisconsin, U.S.A.
,
J McFarland
The Department of Pediatrics, Cornell Medical College, New York, N.Y., U.S.A., the Institut National de Transfusion Sanguine, Paris, France, and Blood Center of Southeast Wisconsin, U.S.A.
,
Working Party on Neonatal Immune Thrombocytopenia of the Neonatal Hemostasis Subcommittee of the Scientific and Standardization Committee of the ISTH › Author Affiliations
Further Information

Publication History

Publication Date:
24 July 2018 (online)

  PDF Download  Permissions and Reprints

Summary

The following recommendations of the Neonatal Hemostasis Subcommittee of the Scientific and Standardization Committee of the ISTH for the management of neonatal immune thrombocytopenia were prepared by the working party on neonatal immune thrombocytopenia. Evaluation, diagnosis, and treatment of the mother and neonate with alloimmune and autoimmune thrombocytopenia are discussed and current recommendations provided. This document is likely to require frequent future revision(s).

 

  • References

  • 1 Hart D, Dunetz C, Nardi M, Porges R, Weiss A, Karpatkin M. An epidemic of maternal thrombocytopenia associated with elevated antiplatelet antibody. Am J Obstet Gynecol 1986; 154: 878-883
    CrossrefPubMedGoogle Scholar
  • 2 Burrows R, Kelton J. Incidentally detected thrombocytopenia in healthy mothers and their infants. N Engl J Med 1988; 319: 142-145
    CrossrefPubMedGoogle Scholar
  • 3 Burrows R, Kelton J. Thrombocytopenia at delivery: A prospective survey of 6715 deliveries. Am J Obstet Gynecol 1990; 162: 731-734
    CrossrefPubMedGoogle Scholar
  • 4 Samuels P, Bussel J, Braitman L, Tomaski A, Druzin M, Mennuti M, Cines D. Estimation of the risk of thrombocytopenia in the offspring of pregnant woman with presumed ITP. N Engl J Med 1990; 323: 229-235
    CrossrefPubMedGoogle Scholar
  • 5 Kaplan C, Daffos F, Forestier F, Tertian G, Catherine N, Pons J, Tchemia F. Fetal platelet counts in thrombocytopenic pregnancy. Lancet (in press)
    PubMedGoogle Scholar
  • 6 Burrows R, Kelton J. Idiopathic thrombocytopenia purpura during pregnancy: Intervention for the fetus is not required. Am J Obstet Gynecol (in press)
    PubMedGoogle Scholar
  • 7 Ballern P, Buskard N, Wittmann B, Wilson R, Effer S, Farquaharson D. ITP in pregnancy: Use of the bleeding time as an indicator for treatment. Blut 1989; 59: 132-135
    CrossrefPubMedGoogle Scholar
  • 8 Cines D, Dusak B, Tomaski A, Mennuti M, Schreiber A. Immune thrombocytopenic purpura and pregnancy. N Engl J Med 1982; 306: 826-831
    CrossrefPubMedGoogle Scholar
  • 9 Ayromlooi J. A new approach to the management of immunologic thrombocytopenic purpura in pregnancy. Am J Obstet Gynecol 1978; 130: 235-236
    CrossrefPubMedGoogle Scholar
  • 10 Scioscia A, Grannum P, Copel J, Hobbins J. The use of percutaneous umbilical blood sampling in immune thrombocytopenic purpura. Am J Obstet Gynecol 1988; 159: 1066-1068
    CrossrefPubMedGoogle Scholar
  • 11 Christiaens G, Helmerhorst F. Validity of intrapartum diagnosis of fetal thrombocytopenia. Am J Obstet Gynecol 1987; 157: 864-865
    CrossrefPubMedGoogle Scholar
  • 12 Pielet B, Socol M, MacGregor S, Ney J, Dooley S. Cordocentesis: An appraisal of risks. Am J Obstet Gynecol 1988; 159: 1497-1500
    CrossrefPubMedGoogle Scholar
  • 13 Daffos F. Technical aspects of prenatal samplings and fetal transfusion. Curr Stud Hematol Blood Transfus 1988; 55: 127-129
    PubMedGoogle Scholar
  • 14 Karpatkin M, Porges R, Karpatkin S. Platelet counts in infants of women with autoimmune thrombocytopenia. Effects of steroid administration to mother. N Engl J Med 1981; 305: 936-939
    CrossrefPubMedGoogle Scholar
  • 15 Christiaens G. Controlled trial of antenatal steroid administration to mothers with ITP. Br J Obstet Gynecol (in press)
    PubMedGoogle Scholar
  • 16 Nathan D, Oski F. Hematology of Infancy and Childhood. Third Edition. W. B. Saunders Company; Philadelphia: 1987
    Google Scholar
  • 17 Ballin A, Andrew M, Ling E, Perlman M, Blanchette V. High dose intravenous gammaglobulin therapy for neonatal autoimmune thrombocytopenia. J Pediatr 1988; 112: 789-792
    CrossrefPubMedGoogle Scholar
  • 18 Bridges J, Carre IJ. Congenital thrombocytopenic purpura treated by exchange transfusion. Arch Dis Child 1961; 36: 210-213
    CrossrefPubMedGoogle Scholar
  • 19 Bauman M, Menitove J, Aster R, Anderson T. Urgent treatment of idiopathic thrombocytopenia purpura with single-dose gammaglobulin infusion followed by platelet transfusion. Ann Intern Med 1986; 104: 808
    CrossrefPubMedGoogle Scholar
  • 20 Blanchette V, Chen L, DeFriedberg A, Hogan V, Trudel E, Decary F. Alloimmunization to the PLA1 platelet antigen: results of a prospective study. Br J Hematol 1990; 74: 209-215
    CrossrefPubMedGoogle Scholar
  • 21 Mueller-Eckhardt C, Mueller-Eckhardt G, Willen-Ohff H, Horz A, Kuenzlen E, O’Neill G, Schendel D. Immunogenicity: Immunogenic-ity of and immune response to the human platelet antigen Zwa is strongly associated with HLA-B8 and DR3. Tissue Antigens 1985; 26: 71-76
    PubMedGoogle Scholar
  • 22 Kaplan C, Daffos F, Forestier F, Cox W, Lyon-Caen E, Dupuy-Montbrun M. Management of alloimmune thrombocytopenia: antenatal diagnosis and in utero transfusion of maternal platelets. Blood 1988; 72: 340-345
    PubMedGoogle Scholar
  • 23 Mueller-Eckhardt C, Mueller-Eckhardt G, Grubert A, Weisheit M, Kief el V, Kroll H, Schmidt S, Santoso S. 348 cases of suspected neonatal alloimmune thrombocytopenia. Lancet 1989; 2: 363-366
    PubMedGoogle Scholar
  • 24 Schulman N, Jordan JV. Platelet immunology. In: Hemostasis and Thrombosis 1988 Coleman RW, Hirsh J, Marder VJ, Salzman FW. (eds)
  • 25 Shibata Y, Miyaji T, Ichikawa Y, Matsuda I. A new platelet system, yuka/yukb. Vox Sang 1986; 51: 334-336
    PubMedGoogle Scholar
  • 26 Friedman J, Aster R. Neonatal alloimmune thrombocytopenic purpura and congenital porencephaly in two siblings associated with a “new” maternal antiplatelet antibody. Blood 1985; 65: 1412-1415
    PubMedGoogle Scholar
  • 27 Bussel J, Berkowitz R, McFarland J, Lynch L, Chitkara U. Antenatal treatment of neonatal alloimmune thrombocytopenia. N Engl J Med 1988; 319: 1374-1378
    CrossrefPubMedGoogle Scholar
  • 28 Forestier F. Biological characterization of prenatal samplings. Curr Stud Hematol Blood Transfus 1988; 55: 130-141
    PubMedGoogle Scholar
  • 29 Lynch L, Bussel J, Goldberg J, Chitkara U, Wilkins I, MacFarland J, Berkowitz R. The in utero diagnosis and management of alloimmune thrombocytopenia. Prenat Diagn 1988; 8: 329-333
    CrossrefPubMedGoogle Scholar
  • 30 Kaplan C, Patereau C, Reznikoff-Etievant M, Muller J, Dumez Y, Kesseler A. Antenatal PLA typing and detection of GP IIb-IIIa complex. Br J Haematol 1985; 60: 586-588
    CrossrefPubMedGoogle Scholar
  • 31 Gruel Y, Boizard B, Daffos F, Forestier F, Caen J, Wautier J. Determination of platelet antigens and glycoprotein in the human fetus. Blood 1986; 68: 488-492
    CrossrefPubMedGoogle Scholar
  • 32 Newman P, Derbes R, Aster R. The human platelet alloantigens PLA1 and PLA2, are associated with a leucine 33/proline 33 amino acid polymorphism in membrane glycoprotein IIIa and are distinguishable by DNA typing. J Clin Invest 1989; 83: 778
    CrossrefPubMedGoogle Scholar
  • 33 Herman J, Jumbelic M, Ancona R, Kickler T. In utero cerebral hemorrhage in alloimmune thrombocytopenia. Am J Ped Hematol Oncol 1986; 8: 32-37
    CrossrefPubMedGoogle Scholar
  • 34 Bussel J. Neonatal alloimmune thrombocytopenia (NAIT): information derived from a prospective international registry. Blood 1987 70. 6a (abstract)
    PubMedGoogle Scholar
  • 35 Bussel J, McFarland J, Berkowitz R. Antenatal management of fetal alloimmune and autoimmune thrombocytopenia. Transfus Med Rev 1990; 2: 49-62
    PubMedGoogle Scholar
  • 36 Daffos F, Forestier F, Kaplan C. Prenatal treatment of fetal alloimmune thrombocytopenia. Lancet 1988; 2: 90 c
    PubMedGoogle Scholar
  • 37 Nicolini U, Rodeck CH, Kochenour NK. et al In-Utero platelet transfusion for alloimmune thrombocytopenia. Lancet 1988; 2: 506
    PubMedGoogle Scholar
  • 38 Daffos F, Forestier F, Muller JY. et al Prenatal treatment of alloimmune thrombocytopenia. Lancet 1984; 2: 632
    PubMedGoogle Scholar